Clinical Trials Logo

Filter by:
NCT ID: NCT04466436 Recruiting - Tryptophan Pathway Clinical Trials

Anaesthesia and Tryptophan Pathway

Start date: July 8, 2020
Phase:
Study type: Observational

Surgery has many immunomodulatory properties of which the mechanism is not clearly understood.

NCT ID: NCT04465617 Recruiting - Mandibular Nerve Clinical Trials

Assessment of the Anterior Loop of the IAN in a Sample of Egyptian Population Using CBCT

Start date: September 1, 2021
Phase:
Study type: Observational

in this study the prevalence & length of the anterior loop of the inferior alveolar nerve will be calculated and measured on retrospective CBCT patient's scans

NCT ID: NCT04465058 Recruiting - COVID19 Clinical Trials

Characteristics of Critically Ill COVID 19 Patients

Start date: July 8, 2020
Phase:
Study type: Observational

COVID19 is n outbreak with unpredictable outcome

NCT ID: NCT04464109 Recruiting - Clinical trials for Evisceration; Traumatic, Eye

Comparative Motility of Alloplastic Orbital Implants

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

This study will evaluate the effect of posterior placement of orbital implants on their motility compared to intrascleral placement after evisceration .

NCT ID: NCT04463966 Recruiting - Clinical trials for Post Partum Hemorrhage

Prevention of Postpartum Haemorrhage

Start date: April 30, 2020
Phase: N/A
Study type: Interventional

Use of Tranexamic Acid for prevention of Postpartum hemorrhage in high risk patients: Randomized Control Trial

NCT ID: NCT04462003 Recruiting - Clinical trials for Deep Vein Thrombosis

Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis

DVT
Start date: July 3, 2019
Phase: Phase 3
Study type: Interventional

The aim of study was to evaluate the efficacy and safety of Apixaban in patients with acute deep venous thrombosis and active malignancy compared with weight adjusted subcutaneous (LMWH). It was hypothesised that Apixaban could be as effective as rivaroxiban and edoxaban in treatment of patients with acute DVT and active malignancy with a lower risk of bleeding especially in those with GIT cancer.

NCT ID: NCT04461340 Recruiting - COVID 19 Clinical Trials

Efficacy and Safety of Sirolimus in COVID-19 Infection

Start date: August 15, 2020
Phase: Phase 2
Study type: Interventional

This research is planned to illustrate the efficacy and safety of sirolimus as an adjuvant agent to the standard treatment protocol against COVID-19 infection

NCT ID: NCT04460443 Recruiting - COVID Clinical Trials

Sofosbuvir in Treatment of COVID 19

Start date: August 1, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients

NCT ID: NCT04460001 Recruiting - Ophthalmopathy Clinical Trials

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Start date: May 16, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

To compare the clinical effectiveness of ranibizumab and combination of ranibizumab and triamcinolone for the treatment of macular oedema secondary to CRVO

NCT ID: NCT04459390 Recruiting - COVID19 Clinical Trials

Association of Comorbidities With COVID19

Start date: July 20, 2020
Phase:
Study type: Observational

Association of Comorbidities with unfavorable COVID19 outcomes as admission to intensive care, invasive ventilation or death.